Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PFL-Alpha Chemotherapy for Early Stage Esophageal Cancer
NCT00004897Phase 2Terminated
- Sponsor
- Northwestern University
- Start
- Oct 1999
- Primary completion
- Jul 2007
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon alfa in esophageal cancer, sponsored by Northwestern University. Started Oct 1999; status: terminated.
02
Drugs
interferon alfa
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00004897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004897.